(Q27852459)

English

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.

scientific article

In more languages

Statements

scholarly article

2 references

13 November 2016

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

based on heuristic

inferred from title

Kirstine Christensen Belling

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Henrik J. Ditzel

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Christina Bjerre

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lena Vinther

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sidse Ø Würtz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Rachita Yadav

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ulrik Lademann

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Olga Rigina

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Khoa Nguyen Do

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anne E Lykkesfeldt

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Henrik Bjørn Nielsen

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Nils Brünner

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anne-Sofie Schrohl

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

24 July 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3839-3851

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

https://scigraph.springernature.com/pub.10.1007/s13277-013-0969-7

0 references

Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Mechanisms of endocrine resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Tissue inhibitor of metalloproteinases-1 in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

TIMP-1 as a tumor marker in breast cancer--an update

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Bioconductor: open software development for computational biology and bioinformatics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Normalization of cDNA microarray data

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Symbolic Description of Factorial Models for Analysis of Variance

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

A human phenome-interactome network of protein complexes implicated in genetic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Reactome: a database of reactions, pathways and biological processes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

NetPath: a public resource of curated signal transduction pathways

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

KEGG for integration and interpretation of large-scale molecular data sets

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Browsing metabolic and regulatory networks with BioCyc

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Paradoxical Action of Fulvestrant in Estradiol-Induced Regression of Tamoxifen-Stimulated Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Role of fulvestrant in the management of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer: results from a double-blind, phase II comparative study (FINDER1).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Non-classical regulation of estrogen receptor-alpha by ICI182,780.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0969-7

21 January 2018

Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23881388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-0969-7

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23881388%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27852459&oldid=1419222109"